approved EB-2 (NIW)

Clinical Pharmacologist

Biomedical Science · Taiwan · 2025-06-03

Processing Time
520 days
Decision Date
2025-06-03
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue cross-disciplinary research at the intersection of biomedical science, pharmacotherapy, and precision medicine, focusing on interactions between drug concentration, pharmacogenes, and the gut microbiome to identify biological markers for personalized treatments in cancers, cardiovascular disease, and metabolic disorders.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's work addresses urgent healthcare needs, supports innovation in therapeutic design, and improves healthcare cost efficiency.

Why This Petition Was Approved

Approval was based on a robust academic track record including 16 peer-reviewed journal articles (7 first-authored), 5 book chapters, 126 citations, and 3 formal peer reviews. The work was further validated by funding from the NIH, NCATS, and the National Science Council of Taiwan.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Expert Letters

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
New York 169 days 2025-04-09
The petitioner proposes to continue research in the development of pharmacokinetics (PK) and pharmacodynamics (PD) studies, specifically focusing on the targeted delivery of anti-tumor and antimicrobial medications. This work involves synthesizing bioactive polymers, spatial metabolomics, and protein engineering to improve therapeutic efficacy. The endeavor aims to advance precision medications that reduce side effects for challenging diseases.

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 110 days 2023-02-02
The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.

Professor

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
87 days 2025-01-13
The petitioner proposes to continue research integrating advanced computational techniques and artificial intelligence to decode complex biological mechanisms and identify new drug targets. This work focuses on streamlining drug discovery processes and improving treatment efficacy for complex diseases such as Acute Myeloid Leukemia (AML).

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
93 days 2023-03-03
The petitioner proposes to refine diagnostic and therapeutic strategies for complex and chronic diseases by integrating molecular profiling, cellular modeling, and translational biomedical analysis. His work leverages multi-omics data and advanced bioanalysis to deepen the mechanistic understanding of disease progression and treatment response. The endeavor aims to translate biological discoveries into actionable improvements in precision medicine and clinical outcomes.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-03.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 520 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist